Socio-demographic and clinical data | Number |
Sex ratio M/F | 6/43 (0.13) |
Age mean (years) | 33.5 (±11.3) |
Disease duration (month) | 60 (±59.3) |
Diagnostic delay (month) | 30.16 (±39.2) |
Clinical manifestations |
|
Cutaneous | 32 (65%) |
Rheumatology | 21 (42%) |
Hematology | 31 (63%) |
Renal | 20 (40%) |
Neurology | 5 (10%) |
Serous | 4 (8%) |
Disease activity | 6.59 (±5.6) |
Treatment data |
|
Corticosteroids | 46 (93%) |
Duration (month) | 36.46 (±53.4) |
Daily dose (mg/day) | 22.61 (±18.9) |
Cumulative dose (mg) | 894.94 (±2618.4) |
Hydroxychloroquine | 48 (97%) |
Immunosuppressive | 18 (36%) |